Protein tyrosine kinases from inhibitors to useful drugs

Protein tyrosine kinases from inhibitors to useful drugs

Leading researchers, from the Novartis group that pioneered Gleevec/Glivec (TM) and around the world, comprehensively survey the state of the art in the drug discovery processes (bio- and chemoinformatics, structural biology, profiling, generation of resistance, etc.) aimed at generating PTK inhibit...

Full description

Saved in:
Bibliographic Details
Other Authors: Fabbro, D. (Editor), McCormick, Frank 1950- (Editor)
Format: Book
Language:English
Published: Totowa, N.J. Humana Press 2006
Series:Cancer drug discovery and development
Subjects:
Protein-Tyrosine Kinases > pharmacology.
Protein-Tyrosine Kinases > therapeutic use
Protein-tyrosine kinase
Neoplasms > drug therapy
Online Access:Click Here to View Status and Holdings.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items